Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

32

Number of overlapping holdings

82.1%

% of XPH's 39 holdings also in IHE

94.1%

% of IHE's 34 holdings also in XPH

Overlap by Weight
Sector Drift (XPH minus IHE)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XPH
Weight
in IHE
Overlap
ELI LILLY & CO 5.1% 26.1% 5.1%
JOHNSON & JOHNSON 4.8% 23.4% 4.8%
ZOETIS INC 4.9% 4.7% 4.7%
MERCK & CO. INC. 4.7% 4.7% 4.7%
ROYALTY PHARMA PLC CLASS A 4.7% 4.6% 4.6%

Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IHE
INTRA-CELLULAR THERAPIES INC 2.8%
AXSOME THERAPEUTICS, INC. 2.8%
PERRIGO CO 2.8%
ELANCO ANIMAL HEALTH, INC. 2.6%
CYMABAY THERAPEUTICS, INC. 2.6%
AMPHASTAR PHARMACEUTICALS INC 2.5%
CASSAVA SCIENCES, INC. 2.0%
REVANCE THERAPEUTICS INC 1.8%
AMYLYX PHARMACEUTICALS, INC. 1.8%
ORGANON & CO. 1.7%
XPH Underweight Relative to IHE
ELI LILLY & CO -20.9%
JOHNSON & JOHNSON -18.7%
ATEA PHARMACEUTICALS, INC. -0.1%
PHIBRO ANIMAL HEALTH CORP-A -0.1%
MERCK & CO. INC. 0.0%
BRISTOL-MYERS SQUIBB CO 0.1%
ACLARIS THERAPEUTICS, INC. 0.1%
ROYALTY PHARMA PLC CLASS A 0.1%
VENTYX BIOSCIENCES, INC. 0.1%
VIATRIS, INC. 0.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY